Regular Article
Characterization of Two UDP Glucuronosyltransferases That Are Predominantly Expressed in Human Colon

https://doi.org/10.1006/bbrc.1998.8843Get rights and content

Abstract

The liver and gastrointestinal tract are major sites of drug metabolism. However, although the UDP glucuronosyltransferase family of drug-metabolizing enzymes has been extensively characterized in the liver, little is known about this family in the gastrointestinal tract. In this work, an analysis of human colon RNA samples revealed the presence of two UDP glucuronosyltransferase forms that could not be detected in human liver. The cDNA encoding these two forms, UGT1A8 and UGT1A10, was synthesized and expressed in COS-7 cells. Both proteins have molecular masses of 56 kDa and are active towards hydroxylated metabolites of the carcinogens, benzo(α)pyrene and 2-acetylaminofluorene. UGT1A8 was most active towards the 10- and 11-hydroxy benzo(α)pyrenes and the preferred 2-acetylaminofluorene metabolites were the 1-, 2-, and 8-hydroxy derivatives. UGT1A10 was most active towards the 11- and 12-hydroxybenzo(α)pyrenes and the 1- and 3-hydroxy derivatives of 2-acetylaminofluorene. Both enzymes were inactive towards the benzo(α)pyrene trans 4, 5 and 7, 8 dihydrodiols. In addition, these UDP glucuronosyltransferases displayed differential activity towards several phenolic substrates. A survey of human tissues indicated that UGT1A8 and UGT1A10 transcripts are predominantly expressed in the gastrointestinal tract, in contrast to most other UDP glucuronosyltransferase forms which are expressed in the liver and other tissues. These results suggest that UGT1A8 and UGT1A10 may play an important role in the metabolism of dietary xenobiotics.

References (24)

  • A.D. Grove et al.

    J. Biol. Chem.

    (1997)
  • P.B. Watkins

    Advanced Drug Delivery Reviews

    (1997)
  • K.F. Ilett et al.

    Pharmacol. Ther.

    (1990)
  • W.H. Peters et al.

    Biochem. Pharmacol.

    (1988)
  • C.P. Strassburg et al.

    J. Biol. Chem.

    (1998)
  • M. Beaulieu et al.

    J. Biol. Chem.

    (1996)
  • B. Mojarrabi et al.

    Biochem. Biophys. Res. Commun.

    (1997)
  • B. Mojarrabi et al.

    Biochem. Biophys. Res. Commun.

    (1996)
  • S. Andersson et al.

    J. Biol. Chem.

    (1989)
  • P.I. Mackenzie et al.

    J. Biol. Chem.

    (1984)
  • S.K. Bansal et al.

    Anal. Biochem.

    (1980)
  • Cited by (102)

    • Evaluation of inhibitors of intestinal UDP-glucuronosyltransferases 1A8 and 1A10 using raloxifene as a substrate in Caco-2 cells: Studies with four flavonoids of Scutellaria baicalensis

      2021, Toxicology in Vitro
      Citation Excerpt :

      UGT1A10 is expressed throughout the tract and, additionally, in the bile ducts (Gregory et al., 2004). These expression patterns suggests that UGT1A8 and UGT1A10 may play an important role in the metabolism of dietary xenobiotics (Mojarrabi and Mackenzie, 1998; Wang et al., 2016). It has been reported that overexpression of the UGT1A enzymes would lead to development of chemotherapeutic drug resistance (Pathania et al., 2018).

    • UDP-Glycosyltransferases

      2018, Comprehensive Toxicology: Third Edition
    • Prevalence of UDP-glucuronosyltransferase polymorphisms (UGT1A6∗2, 1A7∗12, 1A8∗3, 1A9∗3, 2B7∗2, and 2B15∗2) in a Saudi population

      2017, Saudi Pharmaceutical Journal
      Citation Excerpt :

      The UGT1A8 is a very rare form of polymorphism and is expressed entirely in the extra-hepatic tissues of the gastrointestinal tract (Tukey and Strassburg, 2000, 2001). It has been found that UGT1A8 plays a role in the metabolism of dietary and environmental carcinogens (Mojarrabi and Mackenzie, 1998; Nowell et al., 1999; Cheng et al., 1998, 1999). UGT1A8∗3 has been classified as a low-activity protein on various substrates, including a reduction in MPAG (MPA glucuronide metabolite) formation (Huang et al., 2002).

    • The UDP-glucuronosyltransferases: Their role in drug metabolism and detoxification

      2013, International Journal of Biochemistry and Cell Biology
      Citation Excerpt :

      Conversely, the general pattern of UGT expression in the small intestine and colon more closely resemble the liver, with a large number of enzymes exhibiting significant expression (Table 2), and a greater abundance of UGT2B compared with UGT1A. However, expression of UGT2B4 (the most abundant UGT liver) is limited throughout the GIT, while UGT1A7, 1A8 and 1A10, which are essentially absent from human liver are all expressed in the small intestine and colon (Mojarrabi and Mackenzie, 1998; Ohno et al., 2009; Court et al., 2012). It is important to note that these data are generated by quantification of mRNA expression, which is an indirect measure of protein abundance.

    View all citing articles on Scopus

    Abbreviations used are: UGT, Uridine diphosphoglucuronosyltransferase; PCR, polymerase chain reaction; RT, reverse transcription; G3PDH, glyceraldehyde-3-phosphate dehydrogenase; TLC, thin layer chromatography

    1

    Corresponding author. Fax: 61 8 8204 5114. E-mail:[email protected].

    View full text